BDBM553079 N-[4-fluoro-5-(2- morpholin-4-ylpyrimidin- 5-yl)-2-[rac-(3R)-3,4- dimethylpiperazin-1- yl]phenyl]-1-methyl-6- oxo-4-(trifluoromethyl) pyridine-3-carboxamide::US11319299, Example 128

SMILES C[C@H]1CN(CCN1C)c1cc(F)c(cc1NC(=O)c1cn(C)c(=O)cc1C(F)(F)F)-c1cnc(nc1)N1CCOCC1

InChI Key InChIKey=CGLBRJYXTDVSFE-UHFFFAOYSA-N

Data  1 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 553079   

TargetWD repeat-containing protein 5(Human)
Propellon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 553079BDBM553079(N-[4-fluoro-5-(2- morpholin-4-ylpyrimidin- 5-yl)-2...)
Affinity DataKd:  6.36nMAssay Description:Exemplary compounds of the application were dissolved in 100% DMSO at 10 mM, assayed fresh, and then stored at −20° C. for repeat studies and o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
US Patent